Stromal effects in breast cancer

New England Journal of Medicine

Volumn 357, Issue 25, 2007, Pages 2537-2538

  Liu, Edison T ^a  

^a GENOME INSTITUTE OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN P53;

BREAST CANCER; BREAST CARCINOGENESIS; CANCER RESEARCH; EPITHELIUM CELL; FIBROBLAST; GENE MUTATION; HUMAN; LYMPH NODE METASTASIS; MESENCHYME CELL; PRIORITY JOURNAL; PROGNOSIS; SHORT SURVEY; STROMA; STROMA CELL; TUMOR SUPPRESSOR GENE;

EID: 37349028831     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMp0707576     Document Type: Article

References (5)

1. Sneddon JB, Zhen HH, Montgomery K, et al. Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci U S A 2006;103:14842-7.
2. Aprelikova O, Pace AJ, Fang B, Koller BH, Liu ET. BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J Biol Chem 2001;276:25647-50.
3. Radisky DC, Kenny PA, Bissell MJ. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem 2007;101:830-9.
4. Franklin WA, Gazdar AF, Haney J, et al. Widely dispersed p53 mutation in respiratory epithelium: a novel mechanism for field carcinogenesis. J Clin Invest 1997;100:2133-7. [Erratum, J Clin Invest 1997;100:2639.]
5. Stark A, Hulka BS, Joens S, et al. HER-2/neu amplification in benign breast disease and the risk of subsequent breast cancer. J Clin Oncol 2000;18:267-74.